GPRP

CAS No. 67869-62-9

GPRP( —— )

Catalog No. M34267 CAS No. 67869-62-9

GPRP (Gly-Pro-Arg-Pro) is a fibrin polymerization inhibitor that inhibits the interaction between fibrinogen and the platelet membrane glycoprotein IIb/IIIa complex (glycoprotein IIb/IIIa receptor).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GPRP
  • Note
    Research use only, not for human use.
  • Brief Description
    GPRP (Gly-Pro-Arg-Pro) is a fibrin polymerization inhibitor that inhibits the interaction between fibrinogen and the platelet membrane glycoprotein IIb/IIIa complex (glycoprotein IIb/IIIa receptor).
  • Description
    GPRP (Pefa 6003) is a fibrin polymerization inhibitor that inhibits the interaction of fibrinogen with the platelet membrane glycoprotein IIb/IIIa complex (GPIIb/IIIa).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    67869-62-9
  • Formula Weight
    425.48
  • Molecular Formula
    C18H31N7O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : ≥ 50 mg/mL (117.51 mM)DMSO : 20.83 mg/mL (48.96 mM; Ultrasonic )
  • SMILES
    C([C@@H](NC(=O)[C@H]1N(C(CN)=O)CCC1)CCCNC(=N)N)(=O)N2[C@H](C(O)=O)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gallistl S, et al. Gly-pro-arg-pro (GPRP) enhances free thrombin. Thromb Res. 1995 Jun 15;78(6):547-50.?
molnova catalog
related products
  • Roxifiban acetate

    Roxifiban acetate(DMP 754 acetate) is a potent GP IIb / IIIa antagonist that exhibits antiplatelet aggregation activity via immune mediation and can be used in the study of human thrombocytopenia.

  • P11

    Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic.

  • TBC3486

    A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM.